Analyze Portfolio
OTC · Healthcare

LogicMark, Inc. (LGMK)

As-reported financials and recent SEC filings for LogicMark, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue
$11.4M
Net income
$-7.5M
Net margin
-65.4%
Diluted EPS
$-13.06
ROE
-45.9%
P/E (TTM)
Market cap
Debt / equity

Income statement (as reported)

LineFY2025FY2024FY2023FY2022FY2021
Revenue$11.4M$9.9M$9.9M$11.9M$10.0M
Gross profit$7.6M$6.6M$6.7M$7.2M$5.8M
Operating income$-7.9M$-7.7M$-15.3M$-6.9M$-7.5M
Net income$-7.5M$-9.0M$-14.6M$-6.9M$-11.7M
Diluted EPS$-13.06$-15.63$-26.58$-12.43$-23.79

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-K2026-05-15
View on EDGAR →
10-Q2026-05-15
View on EDGAR →
SCHEDULE 13G/A2026-05-15
View on EDGAR →
424B32026-04-03
View on EDGAR →
8-K2026-03-27
View on EDGAR →
POS EX2026-03-27
View on EDGAR →
POS EX2026-03-27
View on EDGAR →
10-K2026-03-27
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

Go deeper on LGMK

Search LogicMark, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.